Nicolas Chuvin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Loop Mediated Isothermal Amplification

Top Venues

Science advances

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Estelle Baulu, Célia Gardet, Nicolas Chuvin, Stéphane Depil
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. Science advances 9 (7) (2023)
Estelle Baulu, Célia Gardet, Nicolas Chuvin, Stéphane Depil
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. Science advances 9 (7) (2023)
Estelle Baulu, Célia Gardet, Nicolas Chuvin, Stéphane Depil
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. Science advances 9 (7) (2023)
Estelle Baulu, Célia Gardet, Nicolas Chuvin, Stéphane Depil
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. Science advances 9 (7) (2023)
Paola Bonaventura, Vincent Alcazer, Virginie Mutez, Laurie Tonon, Juliette Martin, Nicolas Chuvin, Emilie Michel, Rasha E Boulos, Yann Estornes, Jenny Valladeau-Guilemond, Alain Viari, Qing Wang, Christophe Caux, Stéphane Depil
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Science advances 8 (4) (2022)
Vincent Alcazer, Paola Bonaventura, Laurie Tonon, Emilie Michel, Virginie Mutez, Clémentine Fabres, Nicolas Chuvin, Rasha E Boulos, Yann Estornes, Véronique Maguer-Satta, Kevin Geistlich, Alain Viari, Klaus H Metzeler, Wolfgang Hiddemann, Aarif M N Batch, Tobias Herold, Christophe Caux, Stéphane Depil
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. American journal of hematology 97 (9) (2022)